Therapeutic Effects of the Bcl-2 Inhibitor on Bleomycin-induced Pulmonary Fibrosis in Mice

Idiopathic pulmonary fibrosis (IPF) is a distressing lung disorder with poor prognosis and high mortality rates. Limited therapeutic options for IPF is a major clinical challenge. Well-known for its anti-apoptotic properties, B-cell lymphoma 2 (Bcl-2) plays a critical role in the pathology of malign...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yicheng, Li, Fei, Zhang, Chao, Geng, Xinwei, Syeda, Madiha Zahra, Du, Xufei, Shao, Zhehua, Hua, Wen, Li, Wen, Chen, Zhihua, Ying, Songmin, Shen, Huahao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529052/
https://www.ncbi.nlm.nih.gov/pubmed/34692765
http://dx.doi.org/10.3389/fmolb.2021.645846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529052/
https://www.ncbi.nlm.nih.gov/pubmed/34692765
http://dx.doi.org/10.3389/fmolb.2021.645846

Ejemplares similares